Abstract:To effectively incorporate in vitro-in silico-based methods into the regulation of consumer product safety, a quantitative connection between product phthalate concentrations and in vitro bioactivity data must be established for the general population. We developed, evaluated, and demonstrated a modeling framework that integrates exposure and pharmacokinetic models to convert product phthalate concentrations into population-scale risks for phthalates and their substitutes. A probabilistic exposure model was developed to generate the distribution of multi-route exposures based on product phthalate concentrations, chemical properties, and human activities. Pharmacokinetic models were developed to simulate population toxicokinetics using Bayesian analysis via the Markov chain Monte Carlo method. Both exposure and pharmacokinetic models demonstrated good predictive capability when compared with worldwide studies. The distributions of exposures and pharmacokinetics were integrated to predict the population distributions of internal dosimetry. The predicted distributions showed reasonable agreement with the U.S. biomonitoring surveys of urinary metabolites. The "source-tooutcome" local sensitivity analysis revealed that food contact materials had the greatest impact on body burden for di(2-ethylhexyl) adipate (DEHA), di-2-ethylhexyl phthalate (DEHP), di(isononyl) cyclohexane-1,2dicarboxylate (DINCH), and di(2-propylheptyl) phthalate (DPHP), whereas the body burden of diethyl phthalate (DEP) was most sensitive to the concentration in personal care products. The upper bounds of predicted plasma concentrations showed no overlap with ToxCast in vitro bioactivity values. Compared with the in vitro-toin vivo extrapolation (IVIVE) approach, the integrated modeling framework has significant advantages in mapping product phthalate concentrations to multi-route risks, and thus is of great significance for regulatory use with a relatively low input requirement. Further integration with new approach methodologies will facilitate these in vitro-in silico-based risk assessments for a broad range of products containing an equally broad range of chemicals.

Study on Physiologically based Pharmacokinetic Model of Vinyl chloride metabolism

Solution of Internal Doses for Inhaled Vinyl Chloride by Physiologically Based Toxicokinetic (PBTK) Model

Development of Physiologically Based Toxicokinetic Models for 3-Monochloropropane-1,2-diol and Glycidol.

Diverse Positional 14C Labeling-Assisted Metabolic Analysis of Pesticides in Rats: the Case of Vanisulfane, a Novel Vanillin-Derived Pesticide

QSAR study on the toxicity of chemical components of Chinese materia medica causing the carcinogenicity of rats

Physiologically Based Pharmacokinetic Modeling for Chlorinated Paraffins in Rats and Humans: Importance of Biliary Excretion.

Vinyl Chloride and High-Fat Diet as a Model of Environment and Obesity Interaction

Prevalence And Persistence Of Chromosomal Damage And Susceptible Genotypes Of Metabolic And Dna Repair Genes In Chinese Vinyl Chloride-Exposed Workers

A physiologically based pharmacokinetic model of diethyl phthalates in humans

Physiologically-based Toxicokinetic Model for the Prediction of Perchlorate Distribution and Its Application.

Health Risk Assessment for Benzene Occupational Exposure Using Physiologically Based Pharmacokinetic Model and Dose-Response Model

Predictions of tissue concentrations of myclobutanil, oxyfluorfen, and pronamide in rat and human after oral exposures via GastroPlusTM physiologically based pharmacokinetic modelling

The Construction and Application of Physiologically Based Toxicokinetic Models for Acrylamide, Glycidamide and Their Biomarkers in Rats and Humans.

Study on Risk Evaluation Based on Occupational Exposure Evaluation and Carcinogenic Risk Simulation

Study on Health Risk Assessment for Benzene-Exposed Workers by Physiologically Based Toxicokinetic Model and Dose-Response Model

Physiologically Based Pharmacokinetic (pbpk) Modeling of Interstrain Variability in Trichloroethylene Metabolism in the Mouse

Study on Carcinogenic Risk Evaluation of Benzene-exposed Workers

Estimation of a safe level for occupational exposure to vinyl chloride using a benchmark dose method in central China.

Physiologically-based toxicokinetic modeling of human dermal exposure to diethyl phthalate: Application to health risk assessment

Genotoxicity in vinyl chloride-exposed workers and its implication for occupational exposure limit.

An Integrated Exposure and Pharmacokinetic Modeling Framework for Assessing Population-Scale Risks of Phthalates and Their Substitutes